Copy to clipboard 
Lincotek signed an agreement to acquire a majority stake in Italy-based Pegasus’ medical division. Mr. Alberto Alaria will take the position of Managing Director of the new entity.
The move serves to bolster the Medical Division of Lincotek Group, which is continuing its global investment program to respond to customer requirements in terms of integrated solutions. Through new technologies and automation, the company is addressing the growing interest of the orthopedic device market in an automated forging service, with the intent to increase efficiency along the supply chain, set new standards around quality and reliability and further reduce lead time.
Established in 2007 in Torino, northern Italy, Pegasus decided in 2019 to expand its forging processes into the medical market. The new facility, with a surface area of around 3,000 sqm, is completely dedicated to orthopedic applications. It is ISO 13485 certified and has an ISO 17025 certified internal laboratory.
The fully robotized forging line, which supports the manufacture of forged implantable parts to customer specifications, is the flagship of a complete production service of forged components. Its capabilities are combined with a AMS-2750-compliant heat treatment furnace, automated pickling line and liquid penetrant inspection unit, laboratory equipment, internal mold manufacturing, robotized deburring and polishing unit and computerized dimensional control.
Lincotek Medical will subsequently offer a new high-volume capacity through single service or fully-integrated solutions to support OEMs with a strategic long-term partnership.
Winfried Schaller, CEO of Lincotek Group, said, “With the acquisition of the majority stake in Pegasus medical division, Lincotek Medical is in a stronger position than ever before to support orthopedic OEMs. By combining this forging service with our existing offering, we are able to help customers stay competitive and get to market even faster.”
Speaking for Pegasus, Alberto Alaria, the company’s Managing Director, said, “Pegasus is proud to enter into partnership with Lincotek Group, which represents a great opportunity to grow our presence in the forged medical implants market with the offering of high-quality products. The new synergies and product integration that will be generated moves us a step ahead and creates the possibility of further strengthening the cooperation with our valued customers.”
Source: Lincotek
